Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

SHPH

Shuttle Pharmaceuticals (SHPH)

Shuttle Pharmaceuticals Holdings Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:SHPH
일자시간출처헤드라인심볼기업
2025/03/1405:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/03/1405:10GlobeNewswire Inc.Shuttle Pharma Announces Closing of $5.75 Million Underwritten OfferingNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/03/1319:36Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/03/1222:24GlobeNewswire Inc.Shuttle Pharma Announces Pricing of $5.75 Million Underwritten OfferingNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/03/1219:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/03/1219:20GlobeNewswire Inc.Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business ActivitiesNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/03/1013:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/03/0520:48Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/03/0107:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/02/2800:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/02/2723:58Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/02/2723:56Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/02/2722:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/02/2700:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/02/2700:45GlobeNewswire Inc.Shuttle Pharma Provides Corporate Update and Reports 2024 ResultsNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/02/2700:20Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/02/0709:34Edgar (US Regulatory)Form 5/A - Annual statement of changes in beneficial ownership of securities: [Amend]NASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/02/0709:33Edgar (US Regulatory)Form 5/A - Annual statement of changes in beneficial ownership of securities: [Amend]NASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/02/0606:55Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/02/0409:30Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/02/0409:30Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/01/2906:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/01/2414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/01/2123:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/01/2123:00GlobeNewswire Inc.Shuttle Pharma Reaches Milestone in Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with GlioblastomaNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/01/1322:56AllPennyStocks.comInvestors Watching Two Small-Caps for News on Potential Major Advancements in Cancer TreatmentsNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/01/0723:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2025/01/0723:00GlobeNewswire Inc.Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025NASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2024/12/1923:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2024/12/1923:00GlobeNewswire Inc.Shuttle Pharma Enters into Sponsored Research Agreement with the University of California, San Francisco to Advance PSMA Development ProgramNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
 검색 관련기사 보기:NASDAQ:SHPH